Central serous chorioretinopathy complicating systemic corticosteroid therapy
- PMID: 9352287
- DOI: 10.1177/112067219700700317
Central serous chorioretinopathy complicating systemic corticosteroid therapy
Abstract
Purpose: To present evidence that systemic corticosteroid therapy may cause central serous chorioretinopathy.
Methods: A 20-year-old male with idiopathic thrombocytopenic purpura was examined during systemic treatment with corticosteroids (100 mg daily).
Results: The patient had central serous chorioretinopathy. Spontaneous recovery accompanied discontinuation of the steroid treatment.
Conclusions: This case provides further evidence that cortisol may play a role in the development of central serous chorioretinopathy.
Similar articles
-
Central serous chorioretinopathy complicating solar retinopathy treated with glucocorticoids.Graefes Arch Clin Exp Ophthalmol. 1999 Feb;237(2):166-8. doi: 10.1007/s004170050213. Graefes Arch Clin Exp Ophthalmol. 1999. PMID: 9987635
-
Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids.Graefes Arch Clin Exp Ophthalmol. 1998 Nov;236(11):876-9. doi: 10.1007/s004170050174. Graefes Arch Clin Exp Ophthalmol. 1998. PMID: 9825265
-
Central serous chorioretinopathy in patients receiving systemic corticosteroid therapy.Can J Ophthalmol. 2005 Apr;40(2):217-21. doi: 10.1016/S0008-4182(05)80040-7. Can J Ophthalmol. 2005. PMID: 16049541 No abstract available.
-
Central serous chorioretinopathy and glucocorticoids.Surv Ophthalmol. 2002 Sep-Oct;47(5):431-48. doi: 10.1016/s0039-6257(02)00338-7. Surv Ophthalmol. 2002. PMID: 12431693 Review.
-
Idiopathic central serous chorioretinopathy.Indian J Ophthalmol. 1998 Sep;46(3):131-7. Indian J Ophthalmol. 1998. PMID: 10085624 Review.
Cited by
-
The relation of somatotypes and stress response to central serous chorioretinopathy.Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2307-2315. doi: 10.1007/s00417-017-3787-6. Epub 2017 Sep 5. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28875245
-
COVID-19 Vaccine-Related Vogt-Koyanagi-Harada Disease Complicated by Central Serous Chorioretinopathy during Treatment Course: Case Report and Literature Review.Vaccines (Basel). 2022 Oct 25;10(11):1792. doi: 10.3390/vaccines10111792. Vaccines (Basel). 2022. PMID: 36366301 Free PMC article.
-
Central Serous Chorioretinopathy Misdiagnosed as Posterior Uveitis and the Vicious Circle of Corticosteroid Therapy.J Ophthalmic Vis Res. 2015 Jul-Sep;10(3):303-8. doi: 10.4103/2008-322X.170352. J Ophthalmic Vis Res. 2015. PMID: 26730317 Free PMC article.
-
Central serous chorioretinopathy: update on pathophysiology and treatment.Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004. Surv Ophthalmol. 2013. PMID: 23410821 Free PMC article. Review.
-
Diagnosis and Treatment of Central Serous Chorioretinopathy in Patients with Scleritis.Medicina (Kaunas). 2023 May 15;59(5):949. doi: 10.3390/medicina59050949. Medicina (Kaunas). 2023. PMID: 37241181 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical